These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16333822)

  • 1. Adverse hypersensitivity reactions to mesna as adjunctive therapy for cyclophosphamide.
    Khaw SL; Downie PA; Waters KD; Ashley DM; Heath JA
    Pediatr Blood Cancer; 2007 Sep; 49(3):341-3. PubMed ID: 16333822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS-side effects induced by Ifosfamide-Mesna in children with osteosarcomas.
    Delépine N; Taillard F; Desbois JG; Cornille H; Delépine G; Jasmin C
    Biomed Pharmacother; 1986; 40(5):173-5. PubMed ID: 3098318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the benefits of sodium 2-mercaptoethane sulfonate (MESNA) therapy for children undergoing high-dose chemotherapy].
    Sato J; Takaue Y; Saito S; Okamoto Y; Hirao A; Shimizu T; Abe T; Watanabe T; Kawano Y; Ninomiya T
    Rinsho Ketsueki; 1993 Jan; 34(1):7-12. PubMed ID: 8450612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe allergic reactions to thiol-based cytoprotective agents mesna and amifostine in a child with a supratentorial primitive neuroectodermal tumor.
    Dorris K; Fouladi M; Davies SM; Perentesis JP; Lawrence JM; Chow LM; Assa'ad A; Uygungil B; Jodele S
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):e250-2. PubMed ID: 21646919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
    J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesna-induced photodistributed dermatosis.
    Lin CY; Keefe M
    Clin Exp Dermatol; 2012 Jun; 37(4):358-60. PubMed ID: 22103595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The uroprotection of mesna on cyclophosphamide cystitis in rats. Its consequences on behaviour and brain activities.
    Menétrey D; Bon K; Michiels JF; Lantéri-Minet M
    C R Acad Sci III; 1999 Jun; 322(6):505-15. PubMed ID: 10457601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.
    Korkmaz A; Oter S; Deveci S; Goksoy C; Bilgic H
    J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypersensitivity to VM-26].
    Köster B; Ritter J; Bode U
    Klin Padiatr; 1984; 196(3):178-80. PubMed ID: 6540829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic reactions to mesna.
    Lancet; 1991 Aug; 338(8763):381-2. PubMed ID: 1677714
    [No Abstract]   [Full Text] [Related]  

  • 12. Variation in administration of cyclophosphamide and mesna in the treatment of childhood malignancies.
    Sievers TD; Lagan MA; Bartel SB; Rasco C; Blanding PJ
    J Pediatr Oncol Nurs; 2001; 18(1):37-45. PubMed ID: 11172408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.
    Dhall G; Grodman H; Ji L; Sands S; Gardner S; Dunkel IJ; McCowage GB; Diez B; Allen JC; Gopalan A; Cornelius AS; Termuhlen A; Abromowitch M; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Jun; 50(6):1169-75. PubMed ID: 18293379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug patch tests in the investigation of a fixed drug eruption subsequent to 2 courses of cyclophosphamide in combination with mesna].
    Delaigue S; Boye T; Pasquine C; Guetta K; Alla P; Ponte-Astoul J; Morand JJ
    Ann Dermatol Venereol; 2015 Jan; 142(1):37-40. PubMed ID: 25600793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesna and furosemide for prevention of cyclophosphamide-induced sterile haemorrhagic cystitis in dogs--a retrospective study.
    Laberke S; Zenker I; Hirschberger J
    Vet Rec; 2014 Mar; 174(10):250. PubMed ID: 24463993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed drug eruption caused by mesna.
    Weiss KM; Jariwala S; Wachs J; Jerschow E
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):377-8. PubMed ID: 21962104
    [No Abstract]   [Full Text] [Related]  

  • 17. Urine mesna excretion after intravenous and oral dosing in ifosfamide-treated children.
    Goren MP; Epelman S; Bush DA
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):237-40. PubMed ID: 15184993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse neonatal hemangiomatosis treatment with cyclophosphamide: a case report.
    Vlahovic A; Simic R; Djokic D; Ceran C
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):858-60. PubMed ID: 19829152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
    Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S
    Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new regimen of MESNA (2-mercaptoethanesulfonate) effectively prevents cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplant recipients.
    Khojasteh NH; Zakerinia M; Ramzi M; Haghshenas M
    Transplant Proc; 2000 May; 32(3):596. PubMed ID: 10812128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.